Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.

Fung, Monica; Kim, Jane; Marty, Francisco M; Schwarzinger, Michaël; Koo, Sophia

Fung, Monica; Kim, Jane; Marty, Francisco M; Schwarzinger, Michaël; Koo, Sophia.

Affiliation

Fung M; Beth Israel Deaconess Medical Center, Department of Internal Medicine, Boston, Massachusetts, United States of America.
Kim J; Harvard Medical School, Boston, Massachusetts, United States of America.
Marty FM; Harvard T.H. Chan School of Public Health, Department of Health Policy and Management, Boston, Massachusetts, United States of America.
Schwarzinger M; Harvard Medical School, Boston, Massachusetts, United States of America.
Koo S; Brigham and Women's Hospital, Division of Infectious Diseases, Boston, Massachusetts, United States of America.

PLoS One ; 10(11): e0140930, 2015.

Article de En | MEDLINE | ID: mdl-26554923

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections opportunistes / Tumeurs hématologiques / Neutropénie fébrile induite par la chimiothérapie / Mannanes / Mycoses / Antifongiques Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2015 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google